Adhera Therapeutics, Inc.

Filing Type: S-8
Filing Date: 20101021

Documents

FORM S-8
S-8
OPINION OF PRYOR CASHMAN LLP
EX-5.1
CEQUENT PHARMACEUTICALS, INC.'S 2006 STOCK INCENTIVE PLAN
EX-10.3
AMENDMENT NO.1 TO CEQUENT PHARMACEUTICALS, INC.'S 2006 STOCK INCENTIVE PLAN
EX-10.4
CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-23.1
CONSENT OF WOLF & COMPANY, P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-23.2